Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levophencynonate Hydrochloride in Vertigo Caused by Posterior Circulation Infarction
NCT02299804Phase 2Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Jan 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phencynonate hydrochloride in vertigo, sponsored by Sihuan Pharmaceutical. Started Jan 2014; status: completed.
02
Drugs
phencynonate hydrochloride
03
Conditions
vertigo
Beyond the preview
Go deeper on NCT02299804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299804.